---
title: "Global GMP cytokine market to grow at 8.4% CAGR from 2025-2031, driven by immunotherapies. Major players include Bio-Techne, PeproTech, CellGenix."
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/269565879.md"
description: "In Dublin, a report on the GMP Cytokine Market predicts significant growth, with a projected CAGR of 8.4% from 2025 to 2031. Key factors driving this growth include the rising demand for immunotherapies, increased use of personalized medicine, and a growing emphasis on cancer research. The global market offers opportunities in the cell/gene therapy sector."
datetime: "2025-12-12T20:32:08.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/269565879.md)
  - [en](https://longbridge.com/en/news/269565879.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/269565879.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/269565879.md) | [English](https://longbridge.com/en/news/269565879.md)


# Global GMP cytokine market to grow at 8.4% CAGR from 2025-2031, driven by immunotherapies. Major players include Bio-Techne, PeproTech, CellGenix.

In Dublin, a report on the GMP Cytokine Market predicts significant growth, with a projected CAGR of 8.4% from 2025 to 2031. Key factors driving this growth include the rising demand for immunotherapies, increased use of personalized medicine, and a growing emphasis on cancer research. The global market offers opportunities in the cell/gene therapy sector.

### 相關股票

- [Bio-Techne (TECH.US)](https://longbridge.com/zh-HK/quote/TECH.US.md)

## 相關資訊與研究

- [Bio-Techne’s New COMET Spatial Tools Might Change The Case For Investing In Bio-Techne (TECH)](https://longbridge.com/zh-HK/news/281130215.md)
- [Cardinal Health Boosts Actinium-225 Production Capacity to Meet Demand for Novel Cancer Therapies](https://longbridge.com/zh-HK/news/281360890.md)
- [AstraZeneca’s rare disease unit posts positive Phase III data for new hypophosphatasia therapy](https://longbridge.com/zh-HK/news/281133098.md)
- [BUZZ-Caribou rises on FDA's regenerative medicine advanced therapy tag for blood cancer therapy](https://longbridge.com/zh-HK/news/281186075.md)
- [Curanex targets cancer cachexia in pipeline expansion to broaden therapeutics focus](https://longbridge.com/zh-HK/news/281520819.md)